Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.

Odutola, A; Ota, MO; Antonio, M; Ogundare, EO; Saidu, Y; Foster-Nyarko, E; Owiafe, PK; Ceesay, F; Worwui, A; Idoko, OT; +14 more... Owolabi, O; Bojang, A; Jarju, S; Drammeh, I; Kampmann, B; Greenwood, BM; Alderson, M; Traskine, M; Devos, N; Schoonbroodt, S; Swinnen, K; Verlant, V; Dobbelaere, K; Borys, D; (2017) Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. Vaccine, 35 (19). pp. 2531-2542. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2017.03.071

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2017.03.071

Abstract

Share

Download

Filename: Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar